Facio selects first series of potential drug development candidates
Posted on January 19th, 20181/19/18
We are sharing this news release from Facio, the Netherlands-based biotech founded by FSHD advocates and business leaders with the sole mission of developing treatments for FSHD. In this story, […]
Filed under: FSHD Research